全文获取类型
收费全文 | 5222篇 |
免费 | 347篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 90篇 |
妇产科学 | 74篇 |
基础医学 | 764篇 |
口腔科学 | 184篇 |
临床医学 | 414篇 |
内科学 | 1163篇 |
皮肤病学 | 70篇 |
神经病学 | 624篇 |
特种医学 | 149篇 |
外科学 | 947篇 |
综合类 | 35篇 |
一般理论 | 3篇 |
预防医学 | 251篇 |
眼科学 | 88篇 |
药学 | 337篇 |
中国医学 | 4篇 |
肿瘤学 | 366篇 |
出版年
2024年 | 8篇 |
2023年 | 41篇 |
2022年 | 85篇 |
2021年 | 152篇 |
2020年 | 94篇 |
2019年 | 131篇 |
2018年 | 169篇 |
2017年 | 135篇 |
2016年 | 133篇 |
2015年 | 146篇 |
2014年 | 241篇 |
2013年 | 241篇 |
2012年 | 427篇 |
2011年 | 445篇 |
2010年 | 224篇 |
2009年 | 211篇 |
2008年 | 373篇 |
2007年 | 341篇 |
2006年 | 305篇 |
2005年 | 302篇 |
2004年 | 234篇 |
2003年 | 238篇 |
2002年 | 224篇 |
2001年 | 41篇 |
2000年 | 24篇 |
1999年 | 39篇 |
1998年 | 66篇 |
1997年 | 36篇 |
1996年 | 38篇 |
1995年 | 34篇 |
1994年 | 29篇 |
1993年 | 25篇 |
1992年 | 21篇 |
1991年 | 33篇 |
1990年 | 22篇 |
1989年 | 21篇 |
1988年 | 15篇 |
1987年 | 16篇 |
1986年 | 25篇 |
1985年 | 36篇 |
1984年 | 21篇 |
1983年 | 18篇 |
1982年 | 18篇 |
1981年 | 12篇 |
1980年 | 19篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1974年 | 9篇 |
1973年 | 13篇 |
1967年 | 8篇 |
排序方式: 共有5593条查询结果,搜索用时 15 毫秒
971.
Ma D Tremblay P Mahngar K Akbari-Asl P Collins J Hudlicky T McNulty J Pandey S 《Investigational new drugs》2012,30(3):1012-1027
The natural compound pancratistatin (PST), isolated from the Hymenocallis littoralis plant, specifically induces apoptosis in many cancer cell lines. Unlike many other chemotherapeutics, PST is not genotoxic
and has minimal adverse effects on non-cancerous cells. However, its availability for preclinical and clinical work is limited
due to its low availability in its natural source and difficulties in its chemical synthesis. Several synthetic analogues
of 7-deoxypancratistatin with different modifications at C-1 were synthesized and screened for apoptosis inducing activity
in human colorectal cancer (CRC) cells. We found that a C-1 acetoxymethyl derivative of 7-deoxypancratistatin, JC-TH-acetate-4
(JCTH-4), was effective in inducing apoptosis in both p53 positive (HCT 116) and p53 negative (HT-29) human CRC cell lines,
demonstrating similar efficacy to that of natural PST. JCTH-4 was able to decrease mitochondrial membrane potential (MMP),
increase levels of reactive oxygen species in isolated mitochondria, cause release of the apoptogenic factor cytochrome c
(Cyto c) from isolated mitochondria, and induce autophagy in HCT 116 and HT-29 cells. Interestingly, when JCTH-4 was administered
with tamoxifen (TAM), there was an enhanced effect in apoptosis induction, reactive oxygen species (ROS) production and Cyto
c release by isolated mitochondria, and autophagic induction by CRC cells. Minimal toxicity was exhibited by a normal human
fetal fibroblast (NFF) and a normal colon fibroblast (CCD-18Co) cell line. Hence, JCTH-4 is a novel compound capable of selectively
inducing apoptosis and autophagy in CRC cells alone and in combination with TAM and may serve as a safer and more effective
alternative to current cancer therapies. 相似文献
972.
973.
974.
Trevor Archer Richard M. Kostrzewa Richard J. Beninger Tomas Palomo 《Neurotoxicity research》2011,19(2):211-234
The notion of staging in the neurodegenerative disorders is modulated by the constant and progressive loss of several aspects of brain structural integrity, circuitry, and neuronal processes. These destructive processes eventually remove individuals?? abilities to perform at sufficient and necessary functional capacity at several levels of disease severity. The classification of (a) patients on the basis of diagnosis, risk prognosis, and intervention outcome, forms the basis of clinical staging, and (b) laboratory animals on the basis of animal model of brain disorder, extent of insult, and dysfunctional expression, provides the components for the clinical staging and preclinical staging , respectively, expressing associated epidemiological, biological, and genetic characteristics. The major focus of clinical staging in the present account stems from the fundamental notions of Braak staging as they describe the course and eventual prognosis for Alzheimer??s disease, Lewy Body dementia, and Parkinson??s disease. Mild cognitive impairment, which expresses the decline in episodic and semantic memory performance below the age-adjusted normal range without marked loss of global cognition or activities of daily living, and the applications of longitudinal magnetic resonance imaging, major instruments for the monitoring of either disease progression in dementia, present important challenges for staging concepts. Although Braak notions present the essential basis for further developments, current staging conceptualizations seem inadequate to comply with the massive influx of information dealing with neurodegenerative processes in brain, advanced both under clinical realities, and discoveries in the laboratory setting. The contributions of various biomarkers of disease progression, e.g., amyloid precursor protein, and neurotransmitter system imbalances, e.g., dopamine receptor supersensitivity and interactive propensities, await their incorporation into the existing staging models thereby underlining the ongoing, dynamic feature of the staging of brain disorders. 相似文献
975.
Ajeganova S Ehrnfelt C Alizadeh R Rohani M Jogestrand T Hafström I Frostegård J 《Rheumatology (Oxford, England)》2011,50(10):1785-1793
976.
Myocardial and pulmonary ischemia during cardiopulmonary bypass has been associated with postoperative cardiac and pulmonary dysfunction, as well as poor outcomes. Beating-heart valve surgery utilizing continuous coronary perfusion with warm oxygenated blood via the antegrade/retrograde routes, is a novel strategy for myocardial protection. Conceptually, it is proposed that maintenance of pulmonary perfusion and ventilation during the cardiopulmonary bypass period also might be advantageous. The most current evidence regarding these evolving techniques and further areas of research are discussed in this article. 相似文献
977.
978.
979.
Lindahl TL Baghaei F Blixter IF Gustafsson KM Stigendal L Sten-Linder M Strandberg K Hillarp A;Expert Group on Coagulation of the External Quality Assurance in Laboratory Medicine in Sweden 《Thrombosis and haemostasis》2011,106(2):371-378
Pancreatic cancer is known to be associated with VTE, but contemporary rates of incidental and symptomatic VTE events and their association with mortality are incompletely understood. We conducted a retrospective cohort study of consecutive pancreatic adenocarcinoma patients at the University of Rochester from 2006-2009. Data were analysed using a Cox model with time-dependent covariates. A total of 1,151 radiologic exams of 135 patients were included. Forty-seven patients (34.8%) experienced VTE including 12 pulmonary emboli (PE), 28 deep-vein thromboses (DVTs) and 47 visceral vein events. Incidental events comprised 33.3% of PEs, 21.4% of DVTs and 100% of visceral VTE. Median (95% CI) conditional survival beyond three months was 233 (162-322) more days for those without VTE, which was significantly greater than 12 (3-60) days for those with DVT as first event (p<0.0001) and 87 (14-322) days with visceral first events (p=0.022). In multivariate analysis, DVT (HR 25, 95% CI 10-63, p <0.0001), PE (HR 8.9, 95% CI 2.5-31.7, p = 0.007) and incidental visceral events (HR 2.6, 95% CI 1.6-4.2, p =0.0001) were all associated with mortality, though anticoagulants reduced these risks by 70% (26-88%, p = 0.009). In conclusion, VTE occurs in over one-third of contemporary pancreatic cancer patients and, whether symptomatic or incidental, is strongly associated with worsened mortality. The role of anticoagulation in treating incidental or visceral VTE warrants further study. 相似文献
980.